What we want versus what we can get: a closer look at failure time endpoints for cardiovascular studies.

摘要: In this article, we review the use of all-cause mortality and composite endpoint as primary propose a recurrent an alternative endpoint. Some general suggestions to trialists practitioners are provided. summary, is issue that needs clarification.